The Quamed project
QUAMED is from now on an autonomous not for profit association
which objective is to contribute to improving access to quality
medicines.
Our will is to arouse consciousness of actors from all the
continents involved in access to quality medicines in developing
countries and to help them reinforce their Quality Assurance
system. We believe that pooling resources is a key factor for
success and that using synergies will enable create the necessary
conditions to have a direct impact on the market on one hand, and
to have the power of advocacy allowing a political impact on the
other hand.
We therefore created this adapted structure and we developed and
keep developing a series of activities aimed at helping you
reinforce your QA and improving your practices in terms of
procurement of pharmaceutical products.
These are the factors which will allow us to reach the ultimate
goal of QUAMED, namely to improve access to medicines of better
quality for the largest number.
*** This site is being redesigned and updated - New version online soon ***
8/20/2017
Medical Product Alert N° 3/2017. Falsified Avastin (bevacizumab) and Sutent (sunitinib malate) circulating in
This Medical Product Alert relates to two falsified medicines discovered by the National Drug Authority, Uganda and reported to WHO.
In July 2017 falsified versions of Avastin (bevacizumab) and Sutent (sunitinib malate) were seized by the National Drug Authority, Uganda. Both products were being distributed in the vicinity of various cancer treatment centres in Kampala, Uganda.
